N. Forcade

Prevalence, Severity, and Treatment of Community-Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Skin and Soft Tissue Infections in 10 Medical Clinics in Texas: A South Texas Ambulatory Research Network (STARNet) Study

M. Parchman, B. Wickes, C. Frei, 2011, The Journal of the American Board of Family Medicine.

Impact of a New Method of Warfarin Management on Patient Satisfaction, Time, and Cost

Kristin L. Bussey-Smith, C. Frei, H. Bussey, 2013, Pharmacotherapy.

Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study

K. Haase, C. Giuliano, C. Alvarez, 2013, BMC Pharmacology and Toxicology.

Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study

K. Haase, C. Giuliano, C. Alvarez, 2012, BMC Infectious Diseases.

Antibacterials as Adjuncts to Incision and Drainage for Adults with Purulent Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infections

C. Frei, R. Talbert, N. Wiederhold, 2012, Drugs.

Response: Re: Trimethoprim-sulfamethoxazole or Clindamycin for Community-Associated MRSA (CA-MRSA) Skin Infections

C. Frei, Monica L Miller, N. Forcade, 2011, The Journal of the American Board of Family Medicine.

Empiric Weight-Based Vancomycin in Intensive Care Unit Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia

C. Frei, K. Thompson, C. Giuliano, 2014, The American journal of the medical sciences.

Impact of empiric weight‐based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin‐resistant Staphylococcus aureus bacteraemia

E. Mortensen, C. Alvarez, A. Blaszczyk, 2014, Journal of clinical pharmacy and therapeutics.